PublishedOctober 29 2025UpdatedOctober 29 2025Jump to comments sectionStay informed with free updatesSimply sign up to the Health sector myFT Digest -- delivered directly to your inbox.Life sciences group Thermo Fisher has sealed an all-cash takeover of drug trial software maker Clario in a deal that values the technology group at up to $9.4bn.The acquisition gives Thermo Fisher access to a platform that is playing a critical role in managing the clinical data essential to drug trials. Clario’s ...